Provided herein is a device for removing residual hydrogen peroxide or hydrazine from an effluent gas stream which includes a metal oxide scrubber material configured to react with residual process gases under increased temperatures. Also provided are systems and methods of using the same.

A noble metal-free lanthanum transition metal perovskite catalyst material. The noble metal-free lanthanum transition metal perovskite catalyst material may include a two phase mixture of a lanthanum transition metal perovskite with an alkali or alkaline earth metal carbonate, a lanthanum transition metal perovskite doped with an alkali or alkaline earth metal, or a combination thereof. The lanthanum transition metal perovskite catalyst material provides direct decomposition of NOx into N.sub.2 and O.sub.2 without the presence of a noble metal and in the presence of excess O.sub.2.

The invention relates to a process of the oxidative dehydrogenation of an alkane containing 2 to 6 carbon atoms and/or the oxidation of an alkene containing 2 to 6 carbon atoms, wherein the alkane and/or alkene is contacted with oxygen in the presence of a catalyst comprising a mixed metal oxide and one or more diluents selected from the group consisting of carbon dioxide, carbon monoxide and steam, and wherein the conversion of the alkane and/or alkene is at least 40%.

Disclosed are a catalyst for synergistic control of oxynitride and mercury and a method for preparing the same. The catalyst includes the following components by mass percentage: a carrier: TiO2 72%-98.6%, active components: V2O5 0.1%-5%, WO3 1%-10%, Cr2O3 0.1%-5% and Nb2O5 0.1%-5%, and a co-catalyst of 0.1%-3%. The present invention can be used for reducing the oxynitrides in a flue gas, meanwhile oxidizing zero-valent mercury into bivalent mercury and then controlling the reactions, has relatively high denitration performance and also has high mercury oxidation performance; compared with current commercial SCR catalysts, the mercury oxidation rate of the catalyst is improved to a great extent, which can adapt to the requirements for mercury removal in China's coal-fired power plants, the conversion rate of SO2/SO3 is relatively low, and the catalyst has a better anti-poisoning ability, and is a new catalyst with a low cost and high performance.

The presently claimed invention provides a layered three-way catalyst composition for purification of exhaust gases from internal combustion engines; said catalyst comprises a first layer comprising i) palladium supported on at least one alumina component and at least one oxygen storage component; and ii) barium oxide; wherein said first layer is essentially free of strontium, and a second layer comprising: i) rhodium supported on at least one zirconia component and/or alumina component; ii) strontium oxide and/or barium oxide; and iii) optionally, palladium supported on at least one alumina component. The presently claimed invention also provides a process for preparing the layered three-way catalyst composition which involves a technique such as incipient wetness impregnation technique(A); co-precipitation technique (B); or co-impregnation technique(C). The process includes preparing a first layer; preparing a second layer; and depositing the second layer on the first layer followed by calcination. The presently claimed invention further provides a a layered three-way catalytic article in which the three-way catalyst composition is deposited on a substrate in a layered fashion and its preparation.

A method for production of vanadium catalysts, including steps of 1) providing a mixture comprising a TiO.sub.2-based support and a composite oxide containing vanadium and antimony; 2) preparing a slurry containing the mixture obtained from step 1), and additive comprising at least one species selected from the group consisting of Si, Al, Zr, Ti, W and Mo, and a solvent; and 3) applying the slurry onto a substrate or processing the slurry into shaped bodies. The vanadium catalysts obtained/obtainable from the method, and use thereof for abatement of nitrogen oxides (NOx).

The oxide-containing particles (transition metal oxide-containing cerium dioxide particle) exert a catalyst performance, and include at least an iron oxide containing an iron component and a manganese oxide containing a manganese component on a surface of each of cerium dioxide particles, wherein the iron oxide and manganese oxide have smaller particle diameters than that of the cerium dioxide particles, and the content rate of the iron oxide and the manganese oxide is within the range of from 15.0% by mass to 35.0% by mass.

The present invention refers to processes for obtaining steam reforming catalysts containing nickel, cerium, lanthanum and copper oxides, free from potassium or alkali metals, preferably with the oxide layer being located externally with a thickness of less than 0.5 mm on the support particle, preferably the support being based on alumina, magnesium aluminate, hexaaluminates or mixtures thereof. The catalysts according to present invention show high activity, resistance to thermal deactivation and resistance to coke accumulation in the steam reforming reaction of hydrocarbons.

The disclosure provides a tri-metallic ferrite oxygen carrier for the chemical looping combustion of carbonaceous fuels. The tri-metallic ferrite oxygen carrier comprises Cu.sub.xFe.sub.yMn.sub.zO.sub.4-δ, where Cu.sub.xFe.sub.yMn.sub.zO.sub.4-δ is a chemical composition. Generally, 0.5≦x≦2.0, 0.2≦y≦2.5, and 0.2≦z≦2.5, and in some embodiments, 0.8≦x≦1.2, y≦1.2, and z≧0.8. The tri-metallic ferrite oxygen carrier may be used in various applications for the combustion of carbonaceous fuels, including as an oxygen carrier for chemical looping combustion.

Provided herein are compositions for preventing, ameliorating, and/or reducing tissue ischemia and/or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and/or blocking TSP1 and/or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival.